Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-040615

Director sold 2,075 shares at $19.34 ($40,132)

From the SEC's structured data for this filing

Trades in this filing

Chrousos Phaedra · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-14 Sale : show line 1 in the form −2,075 $19.34 $40,132 12,925 D
Open-market sales · 2,075 sh · avg $19.34 · $40,132
Loading xslF345X03/doc4.xml…